264 related articles for article (PubMed ID: 19054064)
1. Postelicitation model of allergic contact dermatitis for predicting the efficacy of topical drugs.
Kammeyer A; Bos JD; Teunissen MB
Exp Dermatol; 2009 Jan; 18(1):44-9. PubMed ID: 19054064
[TBL] [Abstract][Full Text] [Related]
2. Extended DNFB-induced contact hypersensitivity models display characteristics of chronic inflammatory dermatoses.
Röse L; Schneider C; Stock C; Zollner TM; Döcke WD
Exp Dermatol; 2012 Jan; 21(1):25-31. PubMed ID: 22151387
[TBL] [Abstract][Full Text] [Related]
3. Dissection of antigenic and irritative effects of epicutaneously applied haptens in mice. Evidence that not the antigenic component but nonspecific proinflammatory effects of haptens determine the concentration-dependent elicitation of allergic contact dermatitis.
Grabbe S; Steinert M; Mahnke K; Schwartz A; Luger TA; Schwarz T
J Clin Invest; 1996 Sep; 98(5):1158-64. PubMed ID: 8787679
[TBL] [Abstract][Full Text] [Related]
4. AWD 12-281, a highly selective phosphodiesterase 4 inhibitor, is effective in the prevention and treatment of inflammatory reactions in a model of allergic dermatitis.
Bäumer W; Gorr G; Hoppmann J; Ehinger AM; Rundfeldt C; Kietzmann M
J Pharm Pharmacol; 2003 Aug; 55(8):1107-14. PubMed ID: 12956900
[TBL] [Abstract][Full Text] [Related]
5. Topical nanocrystalline silver cream suppresses inflammatory cytokines and induces apoptosis of inflammatory cells in a murine model of allergic contact dermatitis.
Bhol KC; Schechter PJ
Br J Dermatol; 2005 Jun; 152(6):1235-42. PubMed ID: 15948987
[TBL] [Abstract][Full Text] [Related]
6. Suppression of different phases of systemic contact hypersensitivity by urocanic acid oxidation products.
Kammeyer A; Garssen J; Sleijffers A; van Loveren H; Eggelte TA; Bos JD; Teunissen MB
Photochem Photobiol; 2004; 80():72-7. PubMed ID: 15339212
[TBL] [Abstract][Full Text] [Related]
7. Detection of contact hypersensitivity to corticosteroids in allergic contact dermatitis patients who do not respond to topical corticosteroids.
Gönül M; Gül U
Contact Dermatitis; 2005 Aug; 53(2):67-70. PubMed ID: 16033397
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of allergic contact dermatitis and ultraviolet radiation-induced tissue swelling in the mouse by topical amiloride.
Gallo RL; Granstein RD
Arch Dermatol; 1989 Apr; 125(4):502-6. PubMed ID: 2930207
[TBL] [Abstract][Full Text] [Related]
9. Topical administration of the pan-Src kinase inhibitors, dasatinib and LCB 03-0110, prevents allergic contact dermatitis in mice.
Jung SH; Sun X; Ryu WS; Yang BS
Br J Dermatol; 2013 Jan; 168(1):112-9. PubMed ID: 23020072
[TBL] [Abstract][Full Text] [Related]
10. Impaired contact hypersensitivity in diet-induced obese mice.
Katagiri K; Arakawa S; Kurahashi R; Hatano Y
J Dermatol Sci; 2007 May; 46(2):117-26. PubMed ID: 17350227
[TBL] [Abstract][Full Text] [Related]
11. Update of immune events in the murine contact hypersensitivity model: toward the understanding of allergic contact dermatitis.
Honda T; Egawa G; Grabbe S; Kabashima K
J Invest Dermatol; 2013 Feb; 133(2):303-15. PubMed ID: 22931926
[TBL] [Abstract][Full Text] [Related]
12. Prostaglandin E(2)-EP(3) signaling suppresses skin inflammation in murine contact hypersensitivity.
Honda T; Matsuoka T; Ueta M; Kabashima K; Miyachi Y; Narumiya S
J Allergy Clin Immunol; 2009 Oct; 124(4):809-18.e2. PubMed ID: 19541354
[TBL] [Abstract][Full Text] [Related]
13. Olopatadine hydrochloride suppresses the rebound phenomenon after discontinuation of treatment with a topical steroid in mice with chronic contact hypersensitivity.
Tamura T; Matsubara M; Hasegawa K; Ohmori K; Karasawa A
Clin Exp Allergy; 2005 Jan; 35(1):97-103. PubMed ID: 15649273
[TBL] [Abstract][Full Text] [Related]
14. Anti-inflammatory and anti-itch activity of sertaconazole nitrate.
Liebel F; Lyte P; Garay M; Babad J; Southall MD
Arch Dermatol Res; 2006 Sep; 298(4):191-9. PubMed ID: 16868738
[TBL] [Abstract][Full Text] [Related]
15. Anti-inflammatory effects of nitric oxide-releasing hydrocortisone NCX 1022, in a murine model of contact dermatitis.
Hyun E; Bolla M; Steinhoff M; Wallace JL; Soldato PD; Vergnolle N
Br J Pharmacol; 2004 Nov; 143(5):618-25. PubMed ID: 15313880
[TBL] [Abstract][Full Text] [Related]
16. [Improved management of allergic contact eczema].
Bruze M
Nord Med; 1995; 110(3):90-2. PubMed ID: 7892126
[TBL] [Abstract][Full Text] [Related]
17. Scratching behavior in spontaneous- or allergic contact-induced dermatitis in NC/Nga mice.
Takahashi N; Arai I; Honma Y; Hashimoto Y; Harada M; Futaki N; Sugimoto M; Nakaike S
Exp Dermatol; 2005 Nov; 14(11):830-7. PubMed ID: 16232305
[TBL] [Abstract][Full Text] [Related]
18. Skin application of ketoprofen systemically suppresses contact hypersensitivity by inducing CD4(+) CD25(+) regulatory T cells.
Atarashi K; Mori T; Yoshiki R; Kabashima K; Kuma H; Tokura Y
J Dermatol Sci; 2009 Mar; 53(3):216-21. PubMed ID: 19157794
[TBL] [Abstract][Full Text] [Related]
19. Macrophages and neutrophils are the targets for immune suppression by glucocorticoids in contact allergy.
Tuckermann JP; Kleiman A; Moriggl R; Spanbroek R; Neumann A; Illing A; Clausen BE; Stride B; Förster I; Habenicht AJ; Reichardt HM; Tronche F; Schmid W; Schütz G
J Clin Invest; 2007 May; 117(5):1381-90. PubMed ID: 17446934
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of dammarane-type triterpenoids with anti-inflammatory activity in vivo.
Scholz D; Baumann K; Grassberger M; Wolff-Winiski B; Rihs G; Walter H; Meingassner JG
Bioorg Med Chem Lett; 2004 Jun; 14(11):2983-6. PubMed ID: 15125973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
